Press Releases May 12, 2026 06:08 PM

Banzai to Host First Quarter 2026 Financial Results Conference Call on Friday, May 15, 2026 at 4:30 p.m. Eastern Time

Banzai International Announces Q1 2026 Financial Results Conference Call for May 15, 2026

By Derek Hwang
Share
Twitter Reddit Facebook LinkedIn
BNZI

Banzai International, a Nasdaq-listed AI-driven sales and marketing technology company, will hold a conference call on May 15, 2026, to discuss its financial results for the first quarter ended March 31, 2026. The call will include a presentation of ongoing initiatives and anticipated milestones, hosted by the company's CEO and CFO.

Banzai to Host First Quarter 2026 Financial Results Conference Call on Friday, May 15, 2026 at 4:30 p.m. Eastern Time
BNZI
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Banzai International will report its Q1 2026 financial results on May 15, 2026, followed by a Q&A session.
  • The company provides AI-powered marketing and sales solutions to over 150,000 customers, including major enterprises such as Amazon, Dell, and Salesforce.
  • The conference call presentation will be accessible via webcast and through the investor relations section of Banzai's website.

SEATTLE, May 12, 2026 (GLOBE NEWSWIRE) -- Banzai International, Inc. (NASDAQ: BNZI) (“Banzai” or the “Company”), a leading AI-powered sales and marketing technology company, will hold a conference call on Friday, May 15, 2026, at 4:30 p.m. Eastern Time to discuss its financial results for the first quarter ended March 31, 2026, as well as review ongoing initiatives and anticipated milestones.

Banzai Founder & CEO Joe Davy and CFO Dean Ditto will host the conference call, followed by a question-and-answer session. The conference call will be accompanied by a presentation, which can be viewed during the webcast or accessed via the investor relations section of the Company’s website here.

To access the call, please use the following information:

Date:Friday, May 15, 2026Time:4:30 p.m. Eastern Time (1:30 p.m. Pacific Time)Webcast Registration:https://my.demio.com/ref/YnxoICmUaK7K8r8E


A replay of the webcast and the presentation utilized during the call will be available in the Company’s investor relations section here.

About Banzai

Banzai is a marketing technology company that provides AI-enabled marketing and sales solutions for businesses of all sizes. On a mission to help their customers grow, Banzai enables companies of all sizes to target, engage, and measure both new and existing customers more effectively. Banzai has over 150,000 customers including Amazon, Dell, Salesforce, Aflac, Thermo Fisher Scientific, RBC Wealth Management, and Fitch Group. Learn more at www.banzai.io. For investors, please visit ir.banzai.io.

Investor Relations
Dean Ditto
Chief Financial Officer, Banzai
206 414-1777
ir.banzai.io

Media
Nancy Norton
Chief Legal Officer, Banzai
media@banzai.io 


Risks

  • Financial results might not meet market expectations, which could impact investor sentiment.
  • Competition in the AI-powered marketing technology sector remains intense, posing challenges to growth.
  • The success of ongoing initiatives and milestones is uncertain and could affect future company performance.

More from Press Releases

Crinetics Presents Full Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH) in Oral Presentation at ENDO 2026 Jun 14, 2026 Crinetics Presents Long Term Data at ENDO 2026 Confirming PALSONIFY™ (paltusotine) Provides Durable, Consistent Acromegaly Control Jun 14, 2026 Celldex Presents Long-Term Barzolvolimab Results Demonstrating Sustained Off-Treatment Improvement in Angioedema in Patients with CSU at the European Academy of Allergy and Clinical Immunology Annual Meeting Jun 14, 2026 Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in CRSwNP in Significant Majority of Participants Treated with Verekitug in the Phase 2 VIBRANT Trial at EAACI 2026 Jun 14, 2026 Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026) Jun 14, 2026